Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

YARW holding history

Yarrow Bioscience, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

YARW overviewAll 13F holders of YARWFull Q2 2026 holdings

Shares (Q2 2026)
58,597
Value
$38.1K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of YARW by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202658,597$38.1K<0.1%−121,187−67.4%ReducedHolders
Q1 2026179,784$107.5K<0.1%+117,023+186.5%AddedHolders
Q4 202562,761$36.4K<0.1%+57,189+1,026.4%AddedHolders
Q3 20255,572$1.87K<0.1%+5,572NewHolders
Q2 20250$00.0%−7,576−100.0%Sold outHolders
Q1 20257,576$12.0K<0.1%+6,945+1,100.6%AddedHolders
Q4 2024631$2.11K<0.1%+617+4,407.1%AddedHolders
Q3 202414$26<0.1%−25,044−99.9%ReducedHolders
Q2 202425,058$49.4K<0.1%+25,042+156,512.5%AddedHolders
Q1 202416$49<0.1%−830−98.1%ReducedHolders
Q4 2023846$1.97K<0.1%+662+359.8%AddedHolders
Q3 2023184$744<0.1%−902−83.1%ReducedHolders
Q2 20231,086$4.45K<0.1%+721+197.5%AddedHolders
Q1 2023365$1.12K<0.1%−2,672−88.0%ReducedConverted for a 1-for-18 splitHolders
Q4 202254,674$8.20K<0.1%+44,217+422.8%AddedHolders
Q3 202210,457$2.00K<0.1%−12−0.1%ReducedHolders
Q2 202210,469$4.00K<0.1%+10,214+4,005.5%AddedHolders
Q1 2022255$00.0%+12+4.9%AddedHolders
Q4 2021243$00.0%−3,801−94.0%ReducedHolders
Q3 20214,044$6.00K<0.1%−3,239−44.5%ReducedHolders
Q2 20217,283$26.0K<0.1%+626+9.4%AddedHolders
Q1 20216,657$46.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.